SLITRK5 is a cellular protein whose normal function appears to suppress bone formation and could be a potential new target for the treatment ofosteoporosis, according to a collaborative study conducted by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cells manifesting the SLITRK5 protein are marked with magenta (left) and a bone-forming osteoblast marker in green (center). These markers were observed in the cancellous bone in the medulla space (top) or on the outer layer covering the bone (bottom). The overlap between these two markers (right) shows that SLITRK5 is found in bone-forming osteoblasts but not in other cell types, helping to make SLITRK5 a target for skeletal disease treatment. Credit: Dr. Matthew Greenblatt and Dr. Jun Sun
There Research was published in the scientific journal Nature Communications.
Read Also
- The renewal of OPPO Watch would arrive at the end of the year and would boast autonomy | Technology May 28, 2021
- Dominican Republic, increasingly aimed at recycling Jun 5, 2022
- Spider-Man 3: Andrew Garfield reveals leaked photo “is Photoshop” Sep 14, 2021
- You may be pleasantly surprised by the price of the Galaxy Note 20 Ultra Jul 13, 2020
- F1, the 2022 calendar is outlined: the Jeddah and Miami GPs in March and early May Aug 12, 2021
- Mohammed bin Rashid issues a law establishing the “Dubai Academic Health Corporation” Jul 17, 2021
- Mercedes and Red Bull: sustainable development | FormulaPassion.it Jul 1, 2021